125 related articles for article (PubMed ID: 37949208)
21. Identification of candidate biomarkers correlated with poor prognosis of breast cancer based on bioinformatics analysis.
Chen G; Yu M; Cao J; Zhao H; Dai Y; Cong Y; Qiao G
Bioengineered; 2021 Dec; 12(1):5149-5161. PubMed ID: 34384030
[TBL] [Abstract][Full Text] [Related]
22. Identification and analysis of hub genes of hypoxia-immunity in type 2 diabetes mellitus.
Li J; Yan N; Li X; He S; Yu X
Front Genet; 2023; 14():1154839. PubMed ID: 37153000
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
Li J; Liu X; Cui Z; Han G
Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
[TBL] [Abstract][Full Text] [Related]
24. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract][Full Text] [Related]
25. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
[TBL] [Abstract][Full Text] [Related]
26. Bioinformatics and network biology approach to identifying type 2 diabetes genes and pathways that influence the progression of breast cancer.
Sarkar MS; Mia MM; Amin MA; Hossain MS; Islam MZ
Heliyon; 2023 May; 9(5):e16151. PubMed ID: 37234659
[TBL] [Abstract][Full Text] [Related]
27. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.
Yu C; Chen F; Jiang J; Zhang H; Zhou M
Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250
[TBL] [Abstract][Full Text] [Related]
28. Common Genetic Aberrations Associated with Metabolic Interferences in Human Type-2 Diabetes and Acute Myeloid Leukemia: A Bioinformatics Approach.
Kyriakou TC; Papageorgis P; Christodoulou MI
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502231
[TBL] [Abstract][Full Text] [Related]
29. Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Hepatocellular Carcinoma.
Su Q; Li W; Zhang X; Wu R; Zheng K; Zhou T; Dong Y; He Y; Wang D; Ran J
Curr Pharm Biotechnol; 2023; 24(8):1035-1058. PubMed ID: 35762549
[TBL] [Abstract][Full Text] [Related]
30. [Analysis of hub genes and molecular mechanisms in non-alcoholic steatohepatitis based on the gene expression omnibus database].
Li LY; Wu JX
Zhonghua Yi Xue Za Zhi; 2021 Nov; 101(40):3317-3322. PubMed ID: 34758532
[No Abstract] [Full Text] [Related]
31. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.
Hu S; Liao Y; Chen L
Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925
[TBL] [Abstract][Full Text] [Related]
32. Identification of potential therapeutic targets associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
Sharma A; Yadav D; Rao P; Sinha S; Goswami D; Rawal RM; Shrivastava N
Comput Biol Med; 2022 Jul; 146():105688. PubMed ID: 35680454
[TBL] [Abstract][Full Text] [Related]
33. Identification of KIF4A and its effect on the progression of lung adenocarcinoma based on the bioinformatics analysis.
Song Y; Tang W; Li H
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33398330
[TBL] [Abstract][Full Text] [Related]
34. Exploring the molecular mechanism underlying the psoriasis and T2D by using microarray data analysis.
Yang L; Zhang L; Du Q; Gong X; Tian J
Sci Rep; 2023 Nov; 13(1):19313. PubMed ID: 37935955
[TBL] [Abstract][Full Text] [Related]
35. Screening and function analysis of hub genes and pathways in hepatocellular carcinoma via bioinformatics approaches.
Zhang L; Huang Y; Ling J; Zhuo W; Yu Z; Shao M; Luo Y; Zhu Y
Cancer Biomark; 2018; 22(3):511-521. PubMed ID: 29843214
[TBL] [Abstract][Full Text] [Related]
36. [Bioinformatics analysis of core differentially expressed genes in hepatitis B virus-related hepatocellular carcinoma].
Yu Y; Cheng J; Mei CZ; Dai YZ
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2022 Nov; 34(5):507-513. PubMed ID: 36464255
[TBL] [Abstract][Full Text] [Related]
37. Transcriptome analyses identify hub genes and potential mechanisms in adenoid cystic carcinoma.
Liu HB; Huang GJ; Luo MS
Medicine (Baltimore); 2020 Jan; 99(2):e18676. PubMed ID: 31914060
[TBL] [Abstract][Full Text] [Related]
38. Identification of the Genetic Association Between Type-2-Diabetes and Pancreatic Cancer.
Liang Y; Chen W; Tang Y; Chen M
Biochem Genet; 2023 Jun; 61(3):1143-1162. PubMed ID: 36484959
[TBL] [Abstract][Full Text] [Related]
39. In silico identification and functional prediction of differentially expressed genes in South Asian populations associated with type 2 diabetes.
Rabby MG; Rahman MH; Islam MN; Kamal MM; Biswas M; Bonny M; Hasan MM
PLoS One; 2023; 18(12):e0294399. PubMed ID: 38096208
[TBL] [Abstract][Full Text] [Related]
40. Developing discriminate model and comparative analysis of differentially expressed genes and pathways for bloodstream samples of diabetes mellitus type 2.
Liu C; Lu L; Kong Q; Li Y; Wu H; Yang W; Xu S; Yang X; Song X; Yang JY; Yang M; Deng Y
BMC Bioinformatics; 2014; 15 Suppl 17(Suppl 17):S5. PubMed ID: 25559614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
